AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$662M
This Quarter Return
+28.09%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.08B
(+14%)
Cap. Flow
-$42.2M
Cap. Flow
% of AUM
-3.91%
Top 10 Holdings %
Top 10 Hldgs %
98.6%
Holding
15
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Kymera Therapeutics
KYMR
|
$21.5M |
| 2 |
Replimune Group
REPL
|
$18.9M |
| 3 |
Dianthus Therapeutics
DNTH
|
$1.64M |
| 4 |
Spero Therapeutics
SPRO
|
$177K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Dyne Therapeutics
DYN
$1.92B
| $288M | 26.71% | 8,020,136 | – | – |
|
|
2
Kymera Therapeutics
KYMR
$2.95B
| $232M | 21.48% | 4,896,462 -453,960 | -8% | -$21.5M |
|
|
THRD
3
DELISTED
Third Harmonic Bio
THRD
| $148M | 13.7% | 10,907,859 | – | – |
|
4
Disc Medicine
IRON
$2.07B
| $123M | 11.43% | 2,509,456 | – | – |
|
5
Q32 Bio
QTTB
$20.9M
| $93.3M | 8.65% | 2,092,106 | – | – |
|
6
Day One Biopharmaceuticals
DAWN
$769M
| $89.6M | 8.3% | 6,430,257 | – | – |
|
7
Korro Bio
KRRO
$217M
| $38M | 3.52% | 1,137,149 | – | – |
|
8
Generation Bio
GBIO
$40.4M
| $20.5M | 1.9% | 8,279,484 | – | – |
|
|
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
| $19.8M | 1.84% | 5,836,874 | – | – |
|
|
TECX
10
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $11.5M | 1.06% | 378,447 | – | – |
|
|
IMA
11
ImageneBio, Inc. Common Stock
IMA
$150M
| $8.68M | 0.8% | 5,018,178 | – | – |
|
|
JBIO
12
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $3.76M | 0.35% | 1,799,232 | – | – |
|
|
13
Dianthus Therapeutics
DNTH
$759M
| $2.11M | 0.2% | 76,979 -60,000 | -44% | -$1.64M |
|
|
14
Spero Therapeutics
SPRO
$116M
| $540K | 0.05% | 402,885 -132,451 | -25% | -$177K |
|
|
15
Replimune Group
REPL
$422M
| – | – | -2,098,300 | Closed | -$18.9M |
|